Upgrade to SI Premium - Free Trial

Amgen's (AMGN) NDA for Etelcalcetide Accepted by FDA

November 6, 2015 4:02 PM
Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's New Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles